Richard J. Rubino

Richard J. Rubino discloses dealings in 2 companies, chiefly Medco Health Solutions Inc and Aerie Pharmaceuticals Inc. In total, 102 filings cover trades dated from 3 March 2006 to 23 February 2021.

In open-market terms, that means 2 purchases worth €164k on one side and 42 sales worth €9.4M on the other. Netting one side against the other leaves €9.3M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 45 share grants and 9 option exercises.

Most recently, on 25 February 2021, the filings show a share grant worth €5,277 in Aerie Pharmaceuticals Inc. The clock since the last published purchase (9 September 2019) now reads 2,602 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.